chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Onset of symptoms was 12/13/2021.  Symptoms included fever, abdominal pain and vomiting.  Brought to ED on 12/19/2021 for suspicion of appendicitis versus nephrolithiasis versus ovarian torsion. Tests were negative.  Reported recent exposure within 2 weeks prior to COVID positive family member along with  presentation for possible sepsis, concerns for Multisystem Inflammatory Syndrome in young ones case was admitted.  Discharged 12/23/2021 with final diagnosis of MIS-C.
Severe arm pain radiating into the axilla without visible ecchymosis or swelling. Symptoms lasted 4-5 days. No treatment and was watched.
Janssen Dose Number: 1/Pfizer Dose Number: 2; Janssen Dose Number: 1/Pfizer Dose Number: 2; Sore arm; sore arm and neck; He cannot turn his head to look to the side or behind him which makes driving and operating machinery difficult. He has full range of motion in arm but not neck; He has full range of motion in arm but not neck; This is a spontaneous report received from contactable reporter(s) (Pharmacist).  A 63 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 13Dec2021 14:30 (Lot number: fj8762) at the age of 63 years as dose 2 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Janssen (Dose Number: 1, Location of injection: Arm Left, Vaccine Administration Time: 02:30 PM, Route of Administration: Intramuscular), administration date: 06Apr2021, when the patient was 62 years old, for COVID-19 immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious), IMMUNISATION (non-serious) all with onset 13Dec2021 14:30, outcome "unknown" and all described as "Janssen Dose Number: 1/Pfizer Dose Number: 2"; PAIN IN EXTREMITY (non-serious) with onset 13Dec2021, outcome "not recovered", described as "Sore arm"; NECK PAIN (non-serious) with onset 13Dec2021, outcome "not recovered", described as "sore arm and neck"; JOINT RANGE OF MOTION DECREASED (non-serious) with onset 13Dec2021, outcome "not recovered", described as "He cannot turn his head to look to the side or behind him which makes driving and operating machinery difficult. He has full range of motion in arm but not neck"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 13Dec2021, outcome "not recovered", described as "He has full range of motion in arm but not neck". The events "sore arm", "sore arm and neck", "he cannot turn his head to look to the side or behind him which makes driving and operating machinery difficult. he has full range of motion in arm but not neck" and "he has full range of motion in arm but not neck" were evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of pain in extremity, neck pain, joint range of motion decreased, musculoskeletal stiffness. No follow-up attempts are possible. No further information is expected.
Pt presented to the medical clinic on 6/26/07 for follow up after ER visit on 6/25/07 in which patient was treated for an allergic reaction to include visible rash with Epi Pen and Benadryl. On presentation on 6/26/07 he continued to c/o lethargy and was given IV NS at that time with improvement in sx. noted. Pt had received Anthrax and Hep B vaccination the previous day.
Information has been received from a registered pharmacist concerning a 22 year old female patient with no pertinent medical history and no known drug reactions or allergies, who on 10-MAY-2012 was vaccinated with the second dose of GARDASIL, intramuscularly (dose and lot number not reported). Concomitant therapy included intravenous vancomycin, ascorbic acid and multivitamins (unspecified). It was reported that, on 10-MAY-2012, the patient experienced panic like attack, with hyperventilation, sweating, trembling and uncontrolled crying that happened in the first several hours after the second dose of GARDASIL was given. It was stated that the patient had had no problems after receiving the first dose of GARDASIL. It was also reported that the patient experienced left side flank pain and lethargy that lasted for 1 week; then the patient experienced pain that went toward the gallbladder area. It was noted that the pain on the left side flank resolved (until approximately 17-MAY-2012), then the patient experienced nausea and then abdominal pain. It was stated that the patient was experiencing occasional panic like attacks, profuse sweating followed by rapid breathing, trouble catching breath and crying which occurred whenever the patient was hyperstimulated (there were a lot of people around or there was a lot going on around the patient). It was reported that the patient was in a long term care facility due to a motorcycle accident (date unknown) "in which the patient had cellulitis" and required long term antibiotic therapy. Laboratory tests included: unspecified scan, complete blood count, basic metabolic panel (dates not provided) and were all reported as "normal". At the time of the report, the patient recovered from left side flank pain and lethargy on approximately 17-MAY-2012 and did not recover from the other symptoms. Panic like attacks add the symptoms were considered disabling by the reporter. Additional information has been requested.
On January 17th I was diagnosed with acute COVID phenomena, I went through three courses of cough medicine prescribed by my doctor on January 18th, 2022. I had a really bad cough to the point I was vomiting and chest congestion/shortness of breath. I quarantined for 14 days and I was still felling really ill, I've done multiple telehealth visits and they gave me another prescription for steroids and cough medicine. This is still an ongoing issue that I have not recovered from and I have a follow up appointment on April 6th, 2022 with my doctor.
Very sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as follows: The patient self reported this case. Age at vaccination was not reported. The patient received dose of Shingles vaccine and felt very sick for 2 days. The patient said he/she would never get another vaccine again.
This spontaneous report as received from a nurse refers to unspecified number of patients with unknown demographics. Patients medical history and current condition was not reported. On 23-DEC-2014 the patients were vaccinated with improperly stored doses of VAQTA (lot # J000366 and expiry date 22-AUG-2014) (unknown strength and dose). No adverse effects reported. The outcome of the event was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Lump on neck; Inflammation; Right arm swollen; Right arm hot to touch; Swollen lymph nodes in neck/ swollen lymph nodes in her underarms; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inflammation in a 57-year-old female patient who received MMR (Priorix) for prophylaxis.   Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis and HBV (Engerix B) (batch number 4jg5y) for prophylaxis.   On 16-AUG-2023, the patient received Priorix, Boostrix (intramuscular, right deltoid) and Engerix B (intramuscular). On 19-AUG-2023, 3 days after receiving Priorix, Boostrix and Engerix B, the patient experienced inflammation (Verbatim: Inflammation), swelling arm (Verbatim: Right arm swollen), skin warm (Verbatim: Right arm hot to touch) and lymphadenopathy cervical (Verbatim: Swollen lymph nodes in neck/ swollen lymph nodes in her underarms). On 20-SEP-2023, the patient experienced local swelling (Verbatim: Lump on neck). The outcome of the inflammation, swelling arm and skin warm were resolved and the outcome of the lymphadenopathy cervical and local swelling were not resolved.   It was unknown if the reporter considered the inflammation, swelling arm, skin warm, lymphadenopathy cervical and local swelling to be related to Priorix, Priorix Pre-Filled Syringe Device, Boostrix and Engerix B.     It was unknown if the company considered the inflammation, swelling arm, skin warm, lymphadenopathy cervical and local swelling to be related to Priorix, Priorix Pre-Filled Syringe Device, Boostrix and Engerix B.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 21-SEP-2023 The reporter Reported that the patient received 3 vaccination and they were all given on the same day. This reporter stated that the vaccines were given in the right deltoid.  On 19th August 2023, 3 days after receiving the vaccines the patient went to let the pharmacist see her right arm and the pharmacist noticed the right arm was swollen and warm to touch.  The patient got home and she noticed her lymph nodes in her underarms and neck were swollen and she did go see her health care professional about this reaction.   The reporter stated that all of these symptoms had resolved with exception of the lymph nodes in her neck are still swollen. The reporter consented to follow up.
chills; the glands in her neck, under her chin were swollen and hurt a little; below knee and feet and toes are crampy; Her mouth has been dry and drinking more water; Her body just feels achy; injection site is sore; does not feel well; her tingling in her legs from the knee to the toe; the glands in her neck, under her chin were swollen and hurt a little; sore arm; weight is a little low at the moment; This is a spontaneous report from a contactable consumer reporting for herself. A 76-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number EM9810; Expiration date: not reported), dose 1 via an unspecified route of administration, administered in left arm (in the muscle in upper arm) on 03Feb2021 (at the age of 76-years-old) as first dose, single for prevention. The patient's medical history and concomitant medications was none. After receiving the first dose, in the afternoon the patient started experiencing side effects of chills, pain in the injection site, the glands in her neck, under her chin were swollen and hurt a little, a very dry mouth and her tingling in her legs from the knee to the toe. The next day morning sore arm was better, but still experiencing the other side effects. Patient was concerned and would like to know if they were normal. The patient reported that she just got the first dose 03Feb2021 and scheduled for second dose on 24Feb2021. Her weight was a little low at the time of report as she was getting dental work done. Patient went to the site and it did not give anything in terms of if anything happened or what to expect. Patient had chills, and the glands around her neck were swollen. The injection site was sore, but she expected that. Her legs below knees and feet are crampy. Because of her age and lives alone, patient just wanted to know if this was normal.  Her mouth was very dry and had been drinking water with lime she squeezed in it. This started after she got vaccinated around 11:00-11:30. Patient just wanted to know what was normal and what was not. She took temperature and does not have a temp 98.1. She just was feeling like she did not feel well. Patient wanted to know if this would pass. The place she got the vaccine, they did not give her any information except the date to return. Patient reported the day before reporting was worse. Her glands were still swollen, but not as bad. Her feet were still crampy and the toes, body just felt achy. Patient would like to know if these symptoms were normal and what the time frame was that she should expect them to continue. Investigation assessments included none. The outcome of the events chills, the glands in her neck, under her chin were swollen and hurt a little, her mouth has been very dry and drinking more water, her body just feels achy, injection site was sore and sore arm was recovering; event of below knee and feet and toes are crampy was not recovered; other events was unknown.  Follow-up attempts are completed. No further information is expected.
One hour after patient left the pharmacy, newer Tech came to RPh on staff and felt as though she gave patient 0.5ml of Moderna vs 0.25ml. Patient is not immunocompromised thus 3rd dose should be 0.25ml. 0.25ml is what the RPh said and did for patient in processing claim. RPh was not in vaccination room at time of administration, however, based on doses remaining doses in Moderna vial vs what was administered that day, pharmacy does not feel that patient got 0.5ml. Pharmacy is documenting this as a just in case. Math showed that patient got correct dose of 0.25ml but  pharmacy manager wanted to document incident. Pharmacy phoned patient right away as soon as administrator told RPh staff what she felt had happened. Administrator left message for patient on voicemail to call back. Patient also left her COVID vaccination card at pharmacy so pharmacy will at least be able to see/talk to her when she comes to pick up her missing card.
Initial and follow-up information has been received from a registered nurse through the Pregnancy registry concerning a 24 year old female smoker of 1/2 pack per day who quit on 25-SEP-2007, with a history of cervical cancer in 2001, and with asthma, hypoglycemia diagnosed in April 2005, and no drug allergies, who on 22-AUG-2007 was vaccinated intramuscularly with a 0.5 mL first dose of Gardasil (Lot# 657617/0384U). Concomitant therapy included albuterol inhaler. Subsequently, the patient was pregnant. The patient's last menstrual period was 04-JUL-2007 and her estimated delivery date was 23-APR-2008. The patient had an office visit. A pregnancy test was performed (no results provided). At the time of the report, the patient's outcome was unknown. No product quality complaint was involved. Follow-up indicated that on 05-NOV-2007 the patient had a spontaneous abortion 16 weeks from her last menstrual period. It was unknown if the products of conception were examined. It was reported that the patient had not seen a doctor for this pregnancy. The patient was seen in the emergency room on 05-NOV-2007 when she learned of the miscarriage. The patient had 3 previous pregnancies with 1 full term delivery, 1 spontaneous abortion, and 1 elective termination. Upon internal review spontaneous abortion was considered to be an other important medical event. Additional information is not expected.
TINGLING AROUND LIPS (CERTAIN THINGS INTENSIFIES IT LIKE CERTAIN COLOGNES, FOOD, TERMITE SPRAY); BURNING SENSATION  ALL THE WAY AROUND LIPS AND ON TONGUE (HAD NO BLISTERS AND NO PHYSICAL SIGNS); NUMEROUS CHEST BRONCHITIS (AND RELATED BREATHING PROBLEMS); COULD NOT EAT ANYTHING; This spontaneous report received from a patient concerned a 67 year old female. The patient's height, and weight were not reported. The patient's past medical history included: 2 sinus infections, and concurrent conditions included: seasonal springtime allergies (As she got older, it got better.), asthma (As a child, had asthma.), and periodically had bronchitis (once or twice a year). The patient was previously treated with fluticasone propionate for seasonal springtime allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for covid-19 prophylaxis. Age at time of vaccination 67 years old. No concomitant medications were reported. On APR-2021, the patient experienced burning sensation all the way around lips and on tongue (had no blisters and no physical signs). On APR-2021, the patient experienced numerous chest bronchitis (and related breathing problems). On APR-2021, the patient experienced could not eat anything. On an unspecified date, the patient experienced tingling around lips (certain things intensifies it like certain colognes, food, termite spray). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from could not eat anything, had not recovered from tingling around lips (certain things intensifies it like certain colognes, food, termite spray), and the outcome of burning sensation all the way around lips and on tongue (had no blisters and no physical signs) and numerous chest bronchitis (and related breathing problems) was not reported. This report was non-serious.
This spontaneous report was received from a medical assistant regarding multiple unspecified number of patients of unknown age and gender. Patient demographics were not reported. Information on concurrent conditions, pertinent medical history and drug allergies of the patients were not reported. On an unknown date (multiple unspecified dates), the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX lot # L025210, expiry date 07-JUL-2017 (dose, #, route, anatomical location and dose units were not reported). Concomitant medication included MMR II, which was the product tab but did not experience a temperature excursion. There were no adverse effects reported. There was no Product Quality Concern (PQC) involved. Temperature at which the product was stored was: a minute of 14.2 Fahrenheit (F) and a maximum of 21.4F, for a time frame of 1 hour. There were no previous temperature excursions reported. Additional information has been requested.
At 8 PM last night, 2/25/2021 patient began to feel nauseous and fatigued.  This morning the symtoms were more pronounced and at 8:45AM she had a temperature of 100.4.  She ate a piece of buttered toast and was drinking water.  Both stayed down.
p/vax pt devel small knot like area on both thighs; T102; areas in both thighs appears as sterile abscess to the vax; no soreness
-felt faint upon receiving vaccine and vomited immediately after -felt sleepy -diarrhea at about 8:30 pm same evening, took Imodium AD and it stopped -next day  dull headache, low-grade fever, extremely lethargic -repressed appetite -foggy head -slightly sore arm
Thursday Sept 3, 2020.  8:30 PM: tired, achey  Friday Sept. 4   :    1:15AM :  woke with chills and shaking temp 101.8  sweating  Friday Sept 4 until around 10:30 nausea and vomiting                     diarrhea temp down to about 99.9  No appetite Felt flu like through Sunday Sept. 6 evening  Sept 6: developed a shingle patch  in the place I get a reoccurrence. Pulsing, redness, hot, blisters deleted in 24 hours. Based on the info online I did not take my usual oral medication which helps stop the progress(valacyclovir HCL  gram). The shingles patch lasted about 7-9 days.
Within 15 minutes was having an itchy throat and coughing but subsided after 30 minutes. At 45 minutes I had a sharp neck spasm on left side and spasmed down to the left shoulder and upper back. pain was so severe I could not turn head.  BY 1 1/2 hours my right side was doing the same thing with excruciating pain. By that evening my entire body- and joints were hurting. As days went by joint pain in hands and feet especially became more and more severe. Neck pain and stiffness did not go away until couple days before the second dose 9/16/21. Due to allergies, I was just kept on Flexeril daily.
She got her vaccine, she didn't have any problems until about 2 days later.  She has tingling, pins and needles usually in her left hand and lasts for up to 2 hours at a time.  It usually subsides as the day goes on, but then sometimes it happens in her right arm and hand as well.  This still continues, and has been bad since 3:00 AM on her left hand today.  She has not gone to the doctor to seek medical advise.  She bruises easily now since having the vaccine.
A report has been received from a Health Professional concerning, subject of unknown gender, who had been receiving Nasal FLUMIST QUADRIVALENT (INTRANASAL). FLUMIST QUADRIVALENT (INTRANASAL) which started on unknown date. The patient received FLUMIST QUADRIVALENT that were two days expired. Patient have reported no adverse effects. The patient experienced sixteen patients received expired FLUMIST QUADRIVALENT which started on 15-Jan-2014. The outcome of the event of sixteen patients received expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious by the reporter.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of PROQUAD (Merck) lot # L040414 with exp. 13-APR-2017 (route and dose were not provided). No adverse effects reported. The temperature range was between 36F and 46F and the time frame was reported as worse case scenario 68 hours. It was also stated that the vaccines were not previously exposed to any temperature excursion. Additional information has been requested.
running and stuff nose; arm sore; running and stuff nose; tired; This spontaneous case was reported by a patient and describes the occurrence of RHINORRHOEA (running and stuff nose), PAIN IN EXTREMITY (arm sore), NASAL CONGESTION (running and stuff nose) and FATIGUE (tired) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20a) for COVID-19 vaccination.     No Medical History was provided by reporter.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced RHINORRHOEA (running and stuff nose) and NASAL CONGESTION (running and stuff nose). 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm sore) and FATIGUE (tired). On 31-Jan-2021, RHINORRHOEA (running and stuff nose), PAIN IN EXTREMITY (arm sore), NASAL CONGESTION (running and stuff nose) and FATIGUE (tired) had resolved.            No treatment information was reported by the reporter.   This case was linked to MOD-2021-397552, MOD-2021-397419 (Patient Link).
Rash and pain at injection site and down arm. Overall feeling of unwellness for 5 days. Rash has not resolved.
3 areas (small) of red flat rash in upper arm; tender to touch; started yesterday.
This spontaneous report was received from a medical assistant regarding unspecified number of patients of unknown demographics. There was no information about concurrent conditions and historical medication. On an unknown date, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB  (dose strength, route and lot number was unknown). No concomitant medication was reported. No adverse event was reported. No product quality complaint was involved. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
PT COMPLAINED OF HEADACHE, SHORTNESS OF BREATH, INCREASED HEART RATE AND CHEST PAIN. PT TOOK IBUPROFEN 400MG FOR HEADACHE. RESTED FOR ABOUT 30 MINUTES AND FELT BETTER. HAD A NURSE MONITOR HIM FOR ANOTHER 30 MINUTES.
Fatigue, fever, nausea, diarrhea, dizziness, headache arm pain,